Your browser doesn't support javascript.
loading
Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
Narimatsu, H; Kami, M; Kato, D; Matsumura, T; Murashige, N; Kusumi, E; Yuji, K; Hori, A; Shibata, T; Masuoka, K; Wake, A; Miyakoshi, S; Morinaga, S; Taniguchi, S.
Affiliation
  • Narimatsu H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Transpl Infect Dis ; 9(1): 11-5, 2007 Mar.
Article in En | MEDLINE | ID: mdl-17313465
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Postoperative Complications / Foscarnet / Cytomegalovirus Infections / Cytomegalovirus / Cord Blood Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2007 Document type: Article Affiliation country: Japón Country of publication: Dinamarca
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Postoperative Complications / Foscarnet / Cytomegalovirus Infections / Cytomegalovirus / Cord Blood Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2007 Document type: Article Affiliation country: Japón Country of publication: Dinamarca